SEC Filing · 6-K
Aurora Cannabis Inc.
SEC Filing
Press release in this filing
Aurora Cannabis Announces Fiscal 2027 First Quarter Results →Company context
Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance, and a deep commitment to patient care. Aurora serves both medical and consumer markets across Canada, Europe, Australia, and New Zealand, with a strategic focus on high-margin opportunities and a medical-first approach. Aurora’s portfolio of trusted, leading brands includes Aurora ®, MedReleaf ®, Pedanios ®, IndiMed™, San Raf ®, Tasty’s ® and Whistler Medical Marijuana Co. ® With world-class GMP-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of Opening the World to Cannabis™.